Please login to the form below

Not currently logged in
Email:
Password:

Envision Pharma Group relocates to support expansion

Office moves in the US prompted by significant growth

logo

As part of its expansion plans, technology and scientific communications agency Envision Pharma Group has moved into two new offices in the US.

The first relocation is of the company's offices in New Jersey, on the east coast of the US. It has combined two of it offices into a larger office site, which has collaborative working spaces and will allow for the continued expansion of its team.

Envision NJ

Envision's new office in New Jersey, US

Envision has also relocated its office in Southport, Conneticut – also located on the east coast of the US. One of the investments made at this new location is The Lab, which is a new space where Envision's teams and clients can engage with the latest technologies enhancing healthcare communications.

Envision Pharma CT

Envision's new office in Conneticut, US

“This location provides greater opportunities for our teams to share ideas and collaborate together. The updates we’ve made have created a high tech, connected workspace that will benefit both our existing and future global medical affairs clients," said Susanne Clark, global lead at Envision Scientific Solutions.

The relocation of these US-based offices comes on the heels of Envision's earlier expansion this year in Horsham and Wilmslow, UK. The company has 12 offices acround the globe, including locations in the US, the UK, Asia Pacific and in Serbia.

17th September 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...